Colorectal cancer
- PMID: 27189416
- PMCID: PMC4874655
- DOI: 10.1038/nrdp.2015.65
Colorectal cancer
Abstract
Colorectal cancer had a low incidence several decades ago. However, it has become a predominant cancer and now accounts for approximately 10% of cancer-related mortality in western countries. The 'rise' of colorectal cancer in developed countries can be attributed to the increasingly ageing population, unfavourable modern dietary habits and an increase in risk factors, such as smoking, low physical exercise and obesity. New treatments for primary and metastatic colorectal cancer have emerged, providing additional options for patients; these treatments include laparoscopic surgery for primary disease, more-aggressive resection of metastatic disease (such as liver and pulmonary metastases), radiotherapy for rectal cancer, and neoadjuvant and palliative chemotherapies. However, these new treatment options have had limited impact on cure rates and long-term survival. For these reasons, and the recognition that colorectal cancer is long preceded by a polypoid precursor, screening programmes have gained momentum. This Primer provides an overview of the current state of the art of knowledge on the epidemiology and mechanisms of colorectal cancer, as well as on diagnosis and treatment.
Conflict of interest statement
T.S. has received honoraria for lectures or advisory boards from Roche, Merck-Serono, Amgen and Bayer. All other authors declare no competing interests.
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4874655/bin/nihms769726f1.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4874655/bin/nihms769726f2.gif)
![Figure 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4874655/bin/nihms769726f3.gif)
![Figure 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4874655/bin/nihms769726f4.gif)
![Figure 5](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4874655/bin/nihms769726f5.gif)
![Figure 6](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4874655/bin/nihms769726f6.gif)
![Figure 7](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4874655/bin/nihms769726f7.gif)
![Figure 8](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4874655/bin/nihms769726f8.gif)
Similar articles
-
Colorectal cancer.Lancet. 2019 Oct 19;394(10207):1467-1480. doi: 10.1016/S0140-6736(19)32319-0. Lancet. 2019. PMID: 31631858 Review.
-
Aspects of survival from colorectal cancer in Denmark.Dan Med J. 2012 Apr;59(4):B4428. Dan Med J. 2012. PMID: 22459726
-
Palliative care and end-stage colorectal cancer management: the surgeon meets the oncologist.World J Gastroenterol. 2014 Jun 28;20(24):7602-21. doi: 10.3748/wjg.v20.i24.7602. World J Gastroenterol. 2014. PMID: 24976699 Free PMC article. Review.
-
Increasing Rates of Surgery for Patients With Nonmalignant Colorectal Polyps in the United States.Gastroenterology. 2018 Apr;154(5):1352-1360.e3. doi: 10.1053/j.gastro.2018.01.003. Epub 2018 Jan 6. Gastroenterology. 2018. PMID: 29317277 Free PMC article.
-
Laparoscopic resection of colorectal cancer facilitates simultaneous surgery of synchronous liver metastases.Colorectal Dis. 2013 Jan;15(1):e21-8. doi: 10.1111/codi.12068. Colorectal Dis. 2013. PMID: 23088162
Cited by
-
Laser-activable murine ferritin nanocage for chemo-photothermal therapy of colorectal cancer.J Nanobiotechnology. 2024 May 29;22(1):297. doi: 10.1186/s12951-024-02566-6. J Nanobiotechnology. 2024. PMID: 38812019 Free PMC article.
-
Mechanisms of metastatic colorectal cancer.Nat Rev Gastroenterol Hepatol. 2024 May 28. doi: 10.1038/s41575-024-00934-z. Online ahead of print. Nat Rev Gastroenterol Hepatol. 2024. PMID: 38806657 Review.
-
Detecting colorectal cancer using genetic and epigenetic biomarkers: screening and diagnosis.J Med Life. 2024 Jan;17(1):4-14. doi: 10.25122/jml-2023-0269. J Med Life. 2024. PMID: 38737656 Free PMC article. Review.
-
Blood-Based Epigenetic Age Acceleration and Incident Colorectal Cancer Risk: Findings from a Population-Based Case-Control Study.Int J Mol Sci. 2024 Apr 29;25(9):4850. doi: 10.3390/ijms25094850. Int J Mol Sci. 2024. PMID: 38732069 Free PMC article.
-
Evaluation of public awareness, knowledge, and attitudes about colorectal cancer screening among the general population in Al-qunfudah.Am J Cancer Res. 2024 Apr 15;14(4):1926-1934. doi: 10.62347/XKUW3822. eCollection 2024. Am J Cancer Res. 2024. PMID: 38726260 Free PMC article.
References
-
- Kuipers EJ, Rösch T, Bretthauer M. Colorectal cancer screening--optimizing current strategies and new directions. Nat Rev Clin Oncol. 2013;10:130–42. Review of current state of art of colorectal cancer screening. - PubMed
-
- Warthin AS. Heredity with reference to carcinoma: as shown by the study of the cases examined in the pathological laboratory of the University of Michigan. Arch Intern Med. 1913;12:546–55. - PubMed
-
- Capelle LG, et al. Risk and epidemiological time trends of gastric cancer in Lynch syndrome carriers in the Netherlands. Gastroenterology. 2010;138:487–92. - PubMed
-
- Vasen HFA, Tomlinson I, Castells A. Clinical management of hereditary colorectal cancer syndromes. Nat Rev Gastroenterol Hepatol. 2015;12:88–97. - PubMed
-
- Papamichael D, et al. Treatment of colorectal cancer in older patients: International Society of Geriatric Oncology (SIOG) consensus recommendations 2013. Ann Oncol. 2014;26:463–476. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical